BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4079283)

  • 1. [Effect of hydralazine on systemic hemodynamics in patients with cardiac insufficiency].
    Koshlia VI
    Klin Med (Mosk); 1985 Oct; 63(10):100-2. PubMed ID: 4079283
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of korvaton and korinfar on systemic circulation in heart failure patients].
    Koshlia VI
    Vrach Delo; 1986 Aug; (8):23-5. PubMed ID: 3776152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic treatment with vasodilators of heart failure. I. Hydralazine treatment].
    Dumitriu M; Costică II; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):349-63. PubMed ID: 6150539
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine in heart failure.
    Chatterjee K
    Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydralazine in patients with severe aortic insufficiency. Effect on ventricular pressure and volume].
    Lanas F; Stokins B; Saavedra J; Opazo JA; Salvatici R; Schulthess L
    Rev Med Chil; 1982 Jan; 110(1):15-20. PubMed ID: 7156546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ
    Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of hydralazine therapy in patients with chronic congestive heart failure].
    Ke YN
    Zhonghua Nei Ke Za Zhi; 1987 Mar; 26(3):149-51, 190. PubMed ID: 3622085
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic Chagas' cardiopathy-- use of vasodilators in uncompensated heart failure].
    Marin-Neto JA; Secches AL; Maciel BC; Gallo Júnior L; Terra-Filho J; Manço JC; Amorin DS
    Arq Bras Cardiol; 1982 Apr; 38(4):291-9. PubMed ID: 7168662
    [No Abstract]   [Full Text] [Related]  

  • 9. [The changes in plasma catecholamine and hemodynamics in the treatment of chronic congestive heart failure with hydralazine].
    Ke YN
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):9-12. PubMed ID: 6745077
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hydralazine in chronic heart failure].
    Conradson TB; Rydén L
    Lakartidningen; 1984 Sep; 81(38):3354-5. PubMed ID: 6482605
    [No Abstract]   [Full Text] [Related]  

  • 11. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamic effects of hydralazine at rest and during exercise, in patients with congestive heart failure (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Stockins B; Saavedra J; Schulthess L
    Rev Med Chil; 1980 Jul; 108(7):599-604. PubMed ID: 7209179
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydralazine pharmacodynamics in the dog.
    Kittleson MD; Hamlin RL
    Am J Vet Res; 1983 Aug; 44(8):1501-5. PubMed ID: 6625299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of oral hydralazine on left ventricular pump function and renal hemodynamics in chronic left heart failure.
    Mathey D; Hanrath P; Polster J; Witte G; Montz R; Bleifeld W
    Eur Heart J; 1980 Feb; 1(1):25-9. PubMed ID: 7285964
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydralazine in the management of left ventricular failure.
    Fitchett DH; Neto JA; Oakley CM; Goodwin JF
    Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose requirements of hydralazine in patients with severe chronic congestive heart failure.
    Packer M; Meller J; Medina N; Gorlin R; Herman MV
    Am J Cardiol; 1980 Mar; 45(3):655-60. PubMed ID: 7355762
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with hydralazine for treatment of otherwise intractable cough in dogs with apparent left-side heart failure.
    Hamlin RL; Kittleson MD
    J Am Vet Med Assoc; 1982 Jun; 180(11):1327-9. PubMed ID: 7096175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of clophelin on the hemodynamics of patients with circulatory insufficiency].
    Akhmedkhanov SSh; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1984; (11):67-71. PubMed ID: 6523213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute and chronic effects of dihydralazine in severe congestive heart failure at rest and during exercise (author's transl)].
    Reifart N; Bunge T; Kaltenbach M; Bussmann WD
    Z Kardiol; 1982 Jan; 71(2):75-81. PubMed ID: 6803467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.